Back
Myriad Genetics Quote, Financials, Valuation and Earnings
Sponsored
MYGN
Sponsored
Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!
Don't miss out-click here for urgent details on the #1 gold play of the year!
Sell
33
MYGN
Myriad Genetics
Last Price:
23.99
Seasonality Move:
11.19%
7 Day Trial
ALL ACCESS PASS
$
7
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.Myriad Genetics Price Quote
$23.99
+0.02 (+-4.46%)
(Updated: October 16, 2024 at 6:09 AM ET)
Myriad Genetics Key Stats
Sell
33
Myriad Genetics (MYGN)
is a Sell
Day range:
$23.80 - $25.25
52-week range:
$13.82 - $29.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.61
P/B ratio:
2.94%
Volume:
751K
Avg. volume:
691.3K
1-year change:
64.86%
Market cap:
$2.2B
Revenue:
$753.2M
EPS:
$-1.81
How Much Does Myriad Genetics Make?
-
How Much Are Myriad Genetics's Sales Annually?
MYGN Revenues are $753.2M -
How Much Profit Does Myriad Genetics's Make A Year?
MYGN net income is -$263.3M
Is Myriad Genetics Growing As A Company?
-
What Is Myriad Genetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15% -
What Is Myriad Genetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Myriad Genetics Stock Price Performance
-
Did Myriad Genetics Stock Go Up Last Month?
Myriad Genetics share price went down by -13.12% last month -
Did MYGN's Share Price Rise Over The Last Year?
MYGN share price rose by 64.86% over the past 1 year
What Is Myriad Genetics 52-Week High & Low?
-
What Is Myriad Genetics’s 52-Week High Share Price?
Myriad Genetics has traded as high as $29.30 over the past 52 weeks -
What Is Myriad Genetics’s 52-Week Low Share Price?
Myriad Genetics has traded as low as $13.82 over the past 52 weeks
Myriad Genetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Myriad Genetics?
-
How Much Debt Does Myriad Genetics Have?
Total long term debt quarterly is $38.8M -
How Much Cash Does Myriad Genetics Have?
Cash and short term investments quarterly total is $97.3M -
What Is Myriad Genetics’s Book Value Per Share?
Book value per share is 8.15
Is Myriad Genetics Cash Flow Positive?
-
What Is MYGN Cash Flow From Operations?
Cash flow from operations (TTM) is -$92.8M -
What Is Myriad Genetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $113M -
What Is Myriad Genetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$28M
Myriad Genetics Return On Invested Capital
-
Is Management Doing A Good Job?
MYGN return on invested capital is -19.92% -
What Is Myriad Genetics Return On Assets?
ROA measures how assets are converting to revenues and is -13.67% -
What Is MYGN Return On Equity?
ROE is a measure of profitability and is -20.96%
Myriad Genetics Earnings Date & Stock Price
-
What Is Myriad Genetics's Stock Price Today?
A single share of MYGN can be purchased today for 23.97 -
What Is Myriad Genetics’s Stock Symbol?
Myriad Genetics trades on the nasdaq under the ticker symbol: MYGN -
When Is Myriad Genetics’s Next Earnings Date?
The next quarterly earnings date for Myriad Genetics is scheduled on November 6, 2024 -
When Is MYGN's next ex-dividend date?
Myriad Genetics's next ex-dividend date is May 26, 2020 -
How To Buy Myriad Genetics Stock?
You can buy Myriad Genetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Myriad Genetics Competitors
-
Who Are Myriad Genetics's Competitors?
Below is a list of companies who compete with Myriad Genetics or are related in some way:
Myriad Genetics Dividend Yield
-
What Is MYGN Dividend Yield?
Myriad Genetics’s dividend yield currently is 0% -
What Is Myriad Genetics’s Payout Ratio?
Myriad Genetics’s payout ratio is 0% -
When Did Myriad Genetics Last Pay A Dividend?
The latest dividend pay date is October 16, 2024 -
What Is Myriad Genetics’s Dividend Per Share?
Myriad Genetics pays a dividend of $0.00 per share
Myriad Genetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 561.68% |
Revenue: | 15.26% | 3.17% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 1 |
Price Target: | 29.71 |
Upside from Last Price: | 23.93% |